Your session is about to expire
← Back to Search
Teen Driving Intervention for Risky Teen Driving
N/A
Recruiting
Led By Jingzhen (Ginger) Yang, PhD, MPH
Research Sponsored by Ginger Yang
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Possess a valid intermediate driver's license issued by the state of Ohio, with proof of car insurance
At least one legal guardian
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one year post-study period
Awards & highlights
Study Summary
This trial is testing whether an intervention that gives feedback to both teens and parents about unsafe driving, as well as communication training for parents, can improve driving outcomes among teen drivers who have committed a traffic violation.
Who is the study for?
This trial is for teens aged 16-17 in Ohio who've been convicted of a moving violation and have a valid intermediate driver's license with car insurance. They must be the primary driver of a vehicle made after 1996, have access to a smartphone with Bluetooth, and not be enrolled in another driving study or unable to drive.Check my eligibility
What is being tested?
The trial tests Steering Teens Safe (STS), an intervention that aims to improve teen driving safety by enhancing parent communication skills. It will compare two groups: one just gets device feedback on driving, while the other also receives virtual communication training for parents.See study design
What are the potential side effects?
Since this is not a medical intervention, there are no traditional side effects. However, participants may experience increased stress or anxiety due to monitoring or changes in family dynamics from enhanced communication.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to one year post-study period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one year post-study period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adoption of the intervention
Frequency of Parent-teen communications
Implementation fidelity
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment2 Interventions
Parents will receive STS, which will include 1) Individualized virtual communication training and a booster session delivered by a traffic safety communication specialist; and 2) An online parent-teen safe driving communication guide. In addition, the Azūga™ in-vehicle device and app will be installed as described above and all feedback features will be enabled. Three types of feedback will be provided to teens: 1) Direct audio feedback; 2) Detailed cumulative driving data; and 3) A customized weekly driving summary report. Parents in this group will receive access to the teen's cumulative driving data and a weekly driving summary report. Additionally, a wireless mini-camera will be installed on the dashboard in teen's car to identify the participating driver using facial verification technology.
Group II: Control GroupActive Control1 Intervention
The Azūga™ in-vehicle driving feedback technology will be installed.32 This driving feedback technology consists of a pager-sized device plugged into the vehicle's on-board diagnostic (OBD) port (installed in the teen's car) and a smartphone app (downloaded on the teen's smartphone). All feedback features will be disabled. Control dyads will receive no driving feedback. The parent will not receive STS. Additionally, a wireless mini-camera will be installed on the dashboard in teen's car to identify the participating driver using facial verification technology.
Find a Location
Who is running the clinical trial?
Ginger YangLead Sponsor
2 Previous Clinical Trials
1,060 Total Patients Enrolled
University of IowaOTHER
443 Previous Clinical Trials
878,510 Total Patients Enrolled
Jingzhen (Ginger) Yang, PhD, MPHPrincipal InvestigatorNationwide Children's Hospital
2 Previous Clinical Trials
1,060 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Intervention Group
- Group 2: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many people are currently being treated with this medication?
"Yes, as of 9/21/2022 this study is still recruiting patients that were originally posted on 9/28/2020. One location is looking for 180 participants in total."
Answered by AI
Does this trial allow people who are relatively young to participate?
"The ideal candidate for this clinical trial is a teenager that is at least 16 years old but not yet 17."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger